Spain Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 31, 2014
99 Pages - SKU: BMI5432537
Countries covered: Spain

Spain Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The deterioration of the Spanish economy and the government's implementation of increasinglyaggressive fiscal austerity policies that focus on cost containment in the healthcare sector seriously hinderthe country's attractiveness to drugmakers. Despite calls made by companies for the implementation of asystem that adequately rewards innovation and supports investment in future medicines, the government islikely to remain committed to fiscal consolidation and will continue to target the pharmaceutical sector - alarge recipient of public healthcare expenditure.

Headline Expenditure Projections

Pharmaceuticals: EUR24.09bn (USD31.79bn) in 2013 to EUR23.03bn (USD30.85bn) in 2014; -4.4% inlocal currency terms and -3.0% in US dollar terms.

Healthcare: EUR101.79bn (USD134.37bn) in 2013 to EUR102.20bn (USD136.95bn) in 2014; +0.4% inlocal currency terms and +1.9% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Namibia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Namibia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Recent comments by the public relations officer of the Ministry of Health and Social Services,Ester Paulus, that ...
Moldova Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors in the shortterm, but with the country opening ...
Ghana Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Ghana Pharmaceuticals and Healthcare Report Q1 2015BMI View: We anticipate that the continuing roll-out of biometric registration and expansion of thecommunity-based health planning and services ...
Central America Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Central America Pharmaceuticals and Healthcare Report Q1 2015BMI View: Central America will continue to offer revenue-generating opportunities for multinationalpharmaceutical companies. An ageing population, favourable tax ...
See all reports like this >>

More Spain Prescription Drugs reports

Vancomycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Vancomycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
Valproic Acid: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Valproic Acid testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and ...
Topirimate: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Topirimate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
Tobramycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Tobramycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!